1. Home
  2. LSTA vs CXAI Comparison

LSTA vs CXAI Comparison

Compare LSTA & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • CXAI
  • Stock Information
  • Founded
  • LSTA 1980
  • CXAI N/A
  • Country
  • LSTA United States
  • CXAI United States
  • Employees
  • LSTA N/A
  • CXAI N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • CXAI EDP Services
  • Sector
  • LSTA Health Care
  • CXAI Technology
  • Exchange
  • LSTA Nasdaq
  • CXAI Nasdaq
  • Market Cap
  • LSTA 20.0M
  • CXAI 22.4M
  • IPO Year
  • LSTA N/A
  • CXAI N/A
  • Fundamental
  • Price
  • LSTA $2.39
  • CXAI $1.13
  • Analyst Decision
  • LSTA Strong Buy
  • CXAI
  • Analyst Count
  • LSTA 1
  • CXAI 0
  • Target Price
  • LSTA $15.00
  • CXAI N/A
  • AVG Volume (30 Days)
  • LSTA 13.3K
  • CXAI 6.2M
  • Earning Date
  • LSTA 05-08-2025
  • CXAI 04-07-2025
  • Dividend Yield
  • LSTA N/A
  • CXAI N/A
  • EPS Growth
  • LSTA N/A
  • CXAI N/A
  • EPS
  • LSTA N/A
  • CXAI N/A
  • Revenue
  • LSTA $1,000,000.00
  • CXAI $7,142,000.00
  • Revenue This Year
  • LSTA N/A
  • CXAI $114.23
  • Revenue Next Year
  • LSTA N/A
  • CXAI N/A
  • P/E Ratio
  • LSTA N/A
  • CXAI N/A
  • Revenue Growth
  • LSTA N/A
  • CXAI N/A
  • 52 Week Low
  • LSTA $1.87
  • CXAI $0.76
  • 52 Week High
  • LSTA $4.20
  • CXAI $5.43
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 60.67
  • CXAI 53.40
  • Support Level
  • LSTA $1.91
  • CXAI $1.03
  • Resistance Level
  • LSTA $2.09
  • CXAI $1.12
  • Average True Range (ATR)
  • LSTA 0.18
  • CXAI 0.17
  • MACD
  • LSTA 0.06
  • CXAI 0.02
  • Stochastic Oscillator
  • LSTA 100.00
  • CXAI 49.22

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About CXAI CXApp Inc.

CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.

Share on Social Networks: